Eloxx Pharmaceuticals, Inc. (ELOX) › Capital ExpendituresEloxx Pharmaceuticals, Inc. (ELOX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $1.1K2011: $2.0K2012: $4.5K2013: $1.3K2014: $3.2K2015: $10.0K2016: $36.0K2017: $237.0K2018: $235.0K2019: $40.0K2021: $89.0K2022: $66.0K$66.0K2010Capital Expenditures (USD)2022Fiscal YearCapital ExpendituresChange YoY2022$66.0K-25.8%2021$89.0K—2019$40.0K-83.0%2018$235.0K-0.8%2017$237.0K+558.3%2016$36.0K+260.0%2015$10.0K+213.1%2014$3.2K+149.3%2013$1.3K-71.3%2012$4.5K+120.2%2011$2.0K+81.5%2010$1.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share